Literature DB >> 8853166

Plasma lipids and lipoproteins in juvenile chronic arthritis.

A Bakkaloglu1, B Kirel, S Ozen, U Saatçi, N Beşbaş.   

Abstract

Altered levels of high density lipoprotein (HDL), low density lipoprotein (LDL), and very-low density lipoprotein (VLDL), as well as apolipoproteins have been previously described in rheumatoid arthritis patients. We have attempted to evaluate the serum triglyceride, total cholesterol, cholesterol in DHL, LDL, apolipoprotein A1 (apo-A1) and apolipoprotein B (apo-B) levels in juvenile chronic arthritis (JCA) and to correlate them with CRP and ESR in the active and non-active stages of JCA. A total of 37 children no fulfilled ARA criteria for the diagnosis of JCA were studied. There were 18 girls and 19 boys. Age range was 2.5-16 years with a mean of 9.5. The mean duration of disease was 1.8 years. Nineteen patients were accepted to have active disease. Eighteen age and sex matched healthy children served as controls. Apo-A1 was significantly lower in the active JCA group when compared to inactive patients and healthy controls (both p < 0.05). There were significant inverse correlations between apo-A1 and both ESR and CRP levels in these patients (r = 0.67, p < 0.05 and r = -0.61, p < 0.-05, respectively). Although mean LDL levels were numerically lower in the JCA patients (67.2 mg/dl in the active and 68.6 mg/dl in the inactive patients) the difference with healthy controls (91.7 mg/dl) was not statistically significant. There was no significant differences in regard to triglyceride, total cholesterol, cholesterol in HDL, and apo-B levels between neither of the groups. We conclude that JCA patients have a dyslipoproteinaemic state with already altered metabolism of lipids at different stages of the chronic inflammation from active to inactive disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8853166     DOI: 10.1007/bf02230355

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Dyslipoproteinemia in juvenile rheumatoid arthritis.

Authors:  N T Ilowite; P Samuel; L Beseler; M S Jacobson
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

2.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

3.  Inflammation-induced changes in rabbit CRP and plasma lipoproteins.

Authors:  V G Cabana; H Gewurz; J N Siegel
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

4.  Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity.

Authors:  K L Svenson; H Lithell; R Hällgren; I Selinus; B Vessby
Journal:  Arch Intern Med       Date:  1987-11

5.  Dyslipoproteinemia in pediatric systemic lupus erythematosus.

Authors:  N T Ilowite; P Samuel; E Ginzler; M S Jacobson
Journal:  Arthritis Rheum       Date:  1988-07

6.  Antilipoprotein antibodies in rheumatoid arthritis.

Authors:  M B Lazarevic; J Vitic; B L Myones; V Mladenovic; N Nanusevic; J L Skosey; W I Swedler
Journal:  Semin Arthritis Rheum       Date:  1993-06       Impact factor: 5.532

7.  Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins.

Authors:  V G Cabana; J N Siegel; S M Sabesin
Journal:  J Lipid Res       Date:  1989-01       Impact factor: 5.922

8.  Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.

Authors:  S Rantapää-Dahlqvist; S Wållberg-Jonsson; G Dahlén
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

9.  Dyslipoproteinemia in the course of active rheumatoid arthritis.

Authors:  M B Lazarevic; J Vitic; V Mladenovic; B L Myones; J L Skosey; W I Swedler
Journal:  Semin Arthritis Rheum       Date:  1992-12       Impact factor: 5.532

10.  Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.

Authors:  B A Beutler; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

View more
  8 in total

1.  Juvenile idiopathic arthritis activity and function ability: deleterious effects in periodontal disease?

Authors:  Camila Pugliese; Roberta T A van der Vinne; Lucia M A Campos; Priscila R Guardieiro; Cynthia Saviolli; Eloisa Bonfá; Rosa M R Pereira; Vilma S Viana; Eduardo F Borba; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2015-12-01       Impact factor: 2.980

2.  HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis.

Authors:  Preethi Mani; Kiyoko Uno; MyNgan Duong; Kathy Wolski; Steven Spalding; M Elaine Husni; Stephen J Nicholls
Journal:  Cardiovasc Diagn Ther       Date:  2016-02

Review 3.  Atherosclerosis in juvenile idiopathic arthritis.

Authors:  Ewa Jednacz; Lidia Rutkowska-Sak
Journal:  Mediators Inflamm       Date:  2012-08-13       Impact factor: 4.711

4.  Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis.

Authors:  Roberta Gonçalves Marangoni; Andre L Hayata; Eduardo F Borba; Pedro M Azevedo; Eloisa Bonfá; Claudia Goldenstein Schainberg
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

5.  Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-α treatment.

Authors:  Kuo-Wei Yeh; Chi-Ming Lee; Chee-Jen Chang; Yu-Jr Lin; Jing-Long Huang
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

6.  Lipoprotein cholesterol fractions are related to markers of inflammation in children and adolescents with juvenile idiopathic arthritis: a cross sectional study.

Authors:  Anna-Helene Bohr; Freddy Karup Pedersen; Claus Henrik Nielsen; Klaus Gottlob Müller
Journal:  Pediatr Rheumatol Online J       Date:  2016-11-11       Impact factor: 3.054

Review 7.  Cardiovascular risk in pediatric-onset rheumatological diseases.

Authors:  Julie Barsalou; Timothy J Bradley; Earl D Silverman
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

8.  Homocysteine and lipid profile in children with Juvenile Idiopathic Arthritis.

Authors:  Marcela Gonçalves; Vânia D'Almeida; Elvira M Guerra-Shinohara; Luciano C Galdieri; Claudio A Len; Maria Odete E Hilário
Journal:  Pediatr Rheumatol Online J       Date:  2007-04-02       Impact factor: 3.054

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.